Presence of Type 1 Diabetes-Related Autoantibodies in Pediatric Population in Bosnia and Herzegovina.
Diabetes mellitus type 1
diabetes mellitus antibodies
immunological markers
Journal
Materia socio-medica
ISSN: 1512-7680
Titre abrégé: Mater Sociomed
Pays: Bosnia and Herzegovina
ID NLM: 101281595
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
17
07
2023
accepted:
25
08
2023
medline:
5
10
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
ppublish
Résumé
Diabetes mellitus type 1 (T1D) is an autoimmune organ-specific disease with a wide range of clinical manifestations, in which the β cells of the pancreatic islets of Langerhans are destroyed by the action of autoreactive T lymphocytes and the formation of autoantibodies against β cell components. Among used serological markers of T1D, anti-glutamic acid decarboxylase antibodies (GAD65), anti-tyrosine phosphatase antibodies (IA2), islet cell antibodies (ICA), insulin autoantibodies (IAA) and anti-zinc transporter antibodies (Zn-T8) are of great significance. This study aimed to analyze presence of type 1 diabetes-related autoantibodies (GAD65, IA2, ICA, IAA and Zn-T8 and effects of age and gender on their occurrence in pediatric population. Sixty seven (N=67) T1D pediatric patients were included in the study. The levels of immunological parameters such as anti-glutamic acid decarboxylase antibodies (GAD-Ab), anti-tyrosine phosphatase antibodies (IA2-Ab), islet cell antibodies (ICA) and insulin autoantibodies (IAA) were determined by chemiluminescence immunoassay (CLIA) and anti-zinc transporter antibodies (Zn-T8-Ab) were determined by enzyme-linked immunosorbent assay (ELISA). For statistical analysis, we used SPSS statistical program. Our study revealed that among 67 patients with T1D (40 male and 27 female), with an average age of 12,1±3,9 years. The average age of diabetes diagnosis was 6,15±3,29 years. 24 (35,8%) cases were positive for GAD65, 15 (22,4%) for ICA, 34 (50,7%) for IAA, 16 (23,9%) for IA2 and 36 (53,7%) for Zn-T8. The largest number of patients had single positive antibody, the most dominated among them was IAA dominated (40,9%), then Zn-T8 (31,8%). According to Spearman correlation test Zn-transporter shows a significant positive correlation with age of the participants (p=0.027) and disease duration (p=0.006). Anti IA2 shows significant negative correlation with HbA1c (p=0.043). Zn-transporter is associated with patients age and duration of T1D. In most cases, patients with T1D are positive for at least one of the specific autoantibodies. Zn-T8 is the most frequently detected and is an important serological marker of type 1 diabetes mellitus. Gender effects on autoantibodies seems to be insignificant, while age alongside disease duration shows important effects.
Sections du résumé
Background
UNASSIGNED
Diabetes mellitus type 1 (T1D) is an autoimmune organ-specific disease with a wide range of clinical manifestations, in which the β cells of the pancreatic islets of Langerhans are destroyed by the action of autoreactive T lymphocytes and the formation of autoantibodies against β cell components. Among used serological markers of T1D, anti-glutamic acid decarboxylase antibodies (GAD65), anti-tyrosine phosphatase antibodies (IA2), islet cell antibodies (ICA), insulin autoantibodies (IAA) and anti-zinc transporter antibodies (Zn-T8) are of great significance.
Objective
UNASSIGNED
This study aimed to analyze presence of type 1 diabetes-related autoantibodies (GAD65, IA2, ICA, IAA and Zn-T8 and effects of age and gender on their occurrence in pediatric population.
Methods
UNASSIGNED
Sixty seven (N=67) T1D pediatric patients were included in the study. The levels of immunological parameters such as anti-glutamic acid decarboxylase antibodies (GAD-Ab), anti-tyrosine phosphatase antibodies (IA2-Ab), islet cell antibodies (ICA) and insulin autoantibodies (IAA) were determined by chemiluminescence immunoassay (CLIA) and anti-zinc transporter antibodies (Zn-T8-Ab) were determined by enzyme-linked immunosorbent assay (ELISA). For statistical analysis, we used SPSS statistical program.
Results
UNASSIGNED
Our study revealed that among 67 patients with T1D (40 male and 27 female), with an average age of 12,1±3,9 years. The average age of diabetes diagnosis was 6,15±3,29 years. 24 (35,8%) cases were positive for GAD65, 15 (22,4%) for ICA, 34 (50,7%) for IAA, 16 (23,9%) for IA2 and 36 (53,7%) for Zn-T8. The largest number of patients had single positive antibody, the most dominated among them was IAA dominated (40,9%), then Zn-T8 (31,8%). According to Spearman correlation test Zn-transporter shows a significant positive correlation with age of the participants (p=0.027) and disease duration (p=0.006). Anti IA2 shows significant negative correlation with HbA1c (p=0.043). Zn-transporter is associated with patients age and duration of T1D.
Conclusion
UNASSIGNED
In most cases, patients with T1D are positive for at least one of the specific autoantibodies. Zn-T8 is the most frequently detected and is an important serological marker of type 1 diabetes mellitus. Gender effects on autoantibodies seems to be insignificant, while age alongside disease duration shows important effects.
Identifiants
pubmed: 37795157
doi: 10.5455/msm.2023.35.190-195
pii: MSM-35-190
pmc: PMC10545919
doi:
Types de publication
Journal Article
Langues
eng
Pagination
190-195Informations de copyright
© 2023 Lamija Zecevic-Pasic, Suzana Tihic-Kapidzic, Snijezana Hasanbegovic, Ermin Begovic, Refet Gojak, Nejra Dzananovic.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Ther Adv Endocrinol Metab. 2023 Jul 25;14:20420188231185958
pubmed: 37529508
Int J Mol Sci. 2023 Jun 11;24(12):
pubmed: 37373160
Int J Mol Sci. 2022 Aug 09;23(16):
pubmed: 36012115
Diabetes Metab Res Rev. 2013 Nov;29(8):646-54
pubmed: 23861236
Curr Diab Rep. 2019 Mar 23;19(5):22
pubmed: 30905013
Afr Health Sci. 2020 Sep;20(3):1337-1343
pubmed: 33402983
Aust Fam Physician. 2015 Apr;44(4):233-5
pubmed: 25901409
Diabetes Care. 2018 Sep;41(9):2026-2044
pubmed: 30093549
Diabetologia. 2021 Dec;64(12):2609-2652
pubmed: 34590174
J Diabetes Investig. 2021 Apr;12(4):510-515
pubmed: 32696593
Nurs Stand. 2022 Jan 5;37(1):61-66
pubmed: 34708622
Pediatr Diabetes. 2022 Dec;23(8):1586-1593
pubmed: 36082496
Diabetologia. 2021 Oct;64(10):2247-2257
pubmed: 34291312
J Diabetes. 2023 Jul;15(7):607-621
pubmed: 37309552
Front Immunol. 2023 Aug 03;14:1219857
pubmed: 37600804
Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14
pubmed: 10707033
Clin Chim Acta. 2018 Mar;478:162-165
pubmed: 29288641
Pediatr Diabetes. 2020 Dec;21(8):1447-1456
pubmed: 32939969
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40
pubmed: 36507649
Indian J Endocrinol Metab. 2020 May-Jun;24(3):256-259
pubmed: 33083265
Pediatr Diabetes. 2023;2023:
pubmed: 37614409